sanguiin-h-6 and Carcinoma

sanguiin-h-6 has been researched along with Carcinoma* in 1 studies

Other Studies

1 other study(ies) available for sanguiin-h-6 and Carcinoma

ArticleYear
Inhibition of A2780 Human Ovarian Carcinoma Cell Proliferation by a Rubus Component, Sanguiin H-6.
    Journal of agricultural and food chemistry, 2016, Feb-03, Volume: 64, Issue:4

    The effects of a red raspberry component, sanguiin H-6 (SH-6), on the induction of apoptosis and the related signaling pathways in A2780 human ovarian carcinoma cells were investigated. SH-6 caused an antiproliferative effect and a severe morphological change resembling that of apoptotic cell death but no effect on the cancer cell cycle arrest. In addition, SH-6 induced an early apoptotic effect and activation of caspases as well as the cleavage of PARP, which is a hallmark of apoptosis. The early apoptotic percentages of A2780 cells exposed to 20 and 40 μM SH-6 were 35.39 and 41.76, respectively. Also, SH-6 caused the activation of mitogen-activated protein kinases (MAPKs), especially p38, and the increase of truncated p15/BID. These results in the present study suggest that the apoptosis of A2780 human ovarian carcinoma cells by SH-6 is mediated by the MAPK p38 and a caspase-8-dependent BID cleavage pathway.

    Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma; Caspase 3; Caspase 8; Cell Line, Tumor; Cell Proliferation; Female; Growth Inhibitors; Humans; Hydrolyzable Tannins; Ovarian Neoplasms; Proto-Oncogene Proteins c-bcl-2; Rubus; Signal Transduction

2016